Evidence map›Paper›PMID 9572265›Full record

ArticleJournal of neurochemistry1998

Evidence for kappa- and mu-opioid receptor expression in C6 glioma cells.

L M Bohn, M M Belcheva, C J Coscia

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurochemistry, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Therapeutic concentration of morphine reduces oxidative stress in glioma cell line.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2014
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

L M BohnE. A. Doisy Department of Biochemistry and Molecular Biology, St. Louis University School of Medicine, Missouri 63104, USA.
M M Belcheva
C J Coscia
Saint Louis University · US

Funding

OPIOID MODULATION OF ASTROCYTE PROLIFERATIONR01DA005412 · NIDA · SAINT LOUIS UNIVERSITY · PI COSCIA, CARMINE JAMES · 1987 to 2008
$2.3M
OPIOID EFFECTS IN C6 GLIOMA CELLSF31DA005766 · NIDA · SAINT LOUIS UNIVERSITY · PI BOHN, LAURA M · 1996 to 1998
–
NHLBI NIH HHS HL5T32 H207050NIDA NIH HHS DA05412NIDA NIH HHS DA05766NIDA NIH HHS F31 DA005766NIDA NIH HHS R01 DA005412
6 · The paper itself

Abstract

The astrocytoma cell line rat C6 glioma has been used as a model system to study the mechanism of various opioid actions. Nevertheless, the type of opioid receptor(s) involved has not been established. Here we demonstrate the presence of high-affinity U69,593, endomorphin-1, morphine, and beta-endorphin binding in desipramine (DMI)-treated C6 cell membranes by performing homologous and heterologous binding assays with [3H]U69,593, [3H]morphine, or 125I-beta-endorphin. Naive C6 cell membranes displayed U69,593 but neither endomorphin-1, morphine, nor beta-endorphin binding. Cross-linking of 125I-beta-endorphin to C6 membranes gave labeled bands characteristic of opioid receptors. Moreover, RT-PCR analysis of opioid receptor expression in control and DMI-treated C6 cells indicate that both kappa- and mu-opioid receptors are expressed. There does not appear to be a significant difference in the level of mu nor kappa receptor expression in naive versus C6 cells treated with DMI over a 20-h period. Collectively, the data indicate that kappa- and mu-opioid receptors are present in C6 glioma cells.

Indexed as

BenzeneacetamidesAnalgesicsAnalgesics, OpioidAnimalsbeta-EndorphinBinding, CompetitiveDesipramineGliomaMorphinePolymerase Chain ReactionPyrrolidinesRatsReceptors, Opioid, kappaReceptors, Opioid, muTranscription, GeneticTumor Cells, CulturedAnalgesicsAnalgesics, OpioidBenzeneacetamidesbeta-EndorphinDesipramineMorphinePyrrolidinesReceptors, Opioid, kappaReceptors, Opioid, muU 69593

Identifiers

PMID9572265
PMCPMC2571951
OpenAlexW2054148822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.